# Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection

> **NCT00556387** · PHASE2 · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** saline
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT00556387
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-12
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study has been withdraw from the IRB. The PI has transferred to another university. The IND was transferred.
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556387, "Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00556387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*